Sympathoadrenal hyperplasia causes renal malformations in Ret(MEN2B)- transgenic mice

American Journal of Pathology

Volumn 155, Issue 6, 1999, Pages 2167-2179

  Gestblom, Carolina ^a   Sweetser, David A ^b   Doggett, Barbara ^a   Kapur, Raj P ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE BETA MONOOXYGENASE; TYROSINE KINASE RECEPTOR;

ADRENAL HYPERPLASIA; ADRENAL MEDULLA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; GENE CONTROL; GENE EXPRESSION; GENE LOSS; GENE MUTATION; KIDNEY AGENESIS; KIDNEY DEVELOPMENT; KIDNEY MALFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYMPATHETIC GANGLION; TRANSGENIC MOUSE;

EID: 0032762397     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65534-4     Document Type: Article

References (52)

1. Bongarzone I, Monzini N, Borrello MG, Carcano C, Ferraresi G, Arighi E, Mondellini P, Della Porta G, Pierotti MA: Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RIα or cyclic AMP-dependent protein kinase A. Mol Cell Biol 1993, 13:358-366
2. Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Della Porta G, Fusca A, Vecchio G: PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thryoid papillary carcinomas. Cell 1990, 60:557-563
3. Santoro M, Dathan NA, Berlingieri MT, Bongarzone I, Paulin C, Grieco M, Pierotti MA, Vecchio G, Fusco A: Molecular characterization of RET/PTC3; a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma. Oncogene 1994, 9:509-516
4. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tunnacliffe A, Ponder BAJ: Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993, 363:458-460
5. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells SA: Mutations in the RET proto-oncogene are associated with MEN2A and FMTC. Hum Mol Genet 1993, 2:851-856
6. Hofstra RM, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Hoppener JW, van Amstel HK, Romeo G, Lips CJM, Buys CHCM: A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 1994, 367:375-376
7. Carlson KM, Dou S, Chi D, Scavarda N, Toshima K, Jackson CE, Wells SAJ, Goodfellow PJ, Donis KH: Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA 1994, 91:1579-1583
8. Mulligan LM, Eng C, Healey CS, Clayton D, Kwok JB, Gardner E, Ponder MA, Frilling A, Jackson CE, Lehnert H, Neumann HPH, Thibodeau SN, Ponder BAJ: Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet 1994, 6:70-74
9. Santoro M, Carlomagno R, Romano A, Bottaro DP, Dathan NA, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus MH, Di Fiore PP: Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B Science 1995, 267:381-383
10. Edery P, Lyonnet S, Mulligan LM, Pelet A, Dow E, Abel L, Holder S. Nihoul-Fekete C, Ponder BA, Munnich A: Mutations of the RET proto-oncogene in Hirschsprung's disease Nature 1994, 367:378-380
11. Romeo G, Ronchetto P, Luo Y, Barone V, Sen M, Ceccherini I, Pasin B, Bocciardi R, Lerone M, Kaariainen H, Martuciello G Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 1394, 367:377-378
12. Yin L, Barone V, Seri M, Bolino A, Bocciardi R, Ceccherini I, Pasini B, Tocco T, Lerone M, Cywes S, Moore S, Vanderwinden JM, Abramowicz MJ, Kristofferson U, Larrson LT, Hamel BCJ, Silengo M, Martuciello G, Romeo G: Heterogeneity and low detection rate of RET mutations in Hirschsprung disease. Eur J Hum Gene: 1994, 2:272-280
13. Attie T, Pelet A, Edery P, Eng C, Mulligan LM, Amiel J, Boutrand L, Beldjord C, Nihoui-Fekete C, Munnich A, Lyonnet S: Diversity of Ret proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum Mol Genet 1995, 4:2407-2408
14. Angrist M, Bolk S, Thiel B, Puffenberger EG, Hofstra RM, Buys CH, Cass DT, Chakravarti A: Mutation analysis of the RET receptor tyrosine kinase Hirschsprung disease. Hum Mol Genet 1995, 4:821-830
15. Amiel J. Salomon R, Attie T, Pelet A, Trang H, Mokhtari M, Gaultier C, Munnich A, Lyonnet S: Mutations of the RET-GDNF signaling pathway in Ondine's curse. Am J Hum Genet 1998, 62:715-717
16. Schuchardt A, D'Agati V, Larsson BL, Costantini F, Pachnis V: Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 1994, 367:380-383
17. Baloh RH, Tansey MG, Lampe PA, Fahrner TJ, Enomoto H, Simburger KS, Leitner ML, Araki T, Johnson EM, Milbrandt J: Artemin, a novel member of the GDNF ligand family supports peripheral, and central neurons, and signals through the GFRα3-RET receptor Neuron 1998, 21:1291-1302
18. Santoro M, Melillo RM, Carlomagno F, Visconti R, De Vita G, Salvatore G, Lupoli G, Fusco A, Vecchio G: Molecular biology of the MEN2 gene. J Intern Med 1998, 243:505-508
19. Lipschutz JH: Molecular development of the kidney: a review of the results of gene disruption studies. Am J Kidney Dis 1998, 31:383-397
20. Cacalano G, Farinas I, Wang L-C, Hagler K, Forgie A, Moore M, Armanini M, Phillips H, Ryan AM, Reichardt LF, Hynes M, Davies A, Rosenthal A GFRα1 is an essential receptor component for GDNF in the developing nervous system, and Kidney Neuron 1998, 21:53-62
21. Enomoto H, Araki T, Jackman A, Heuckerotn RO, Snider WD, Jonnsor EM, Milbrandt J: GFRα1-deficient mice have deficits in the enteric nervous system, and kidneys. Neuron 1998, 21:317-324
22. Rugh R: The Mouse: Its Reproduction and Development. Minneapolis, Burgess Publishing Co, 1967, pp 276-281
23. Orellana SA, Avner ED: Cell and molecular biology of kidney development. Semin Nephrol 1998, 18:233-243
24. Davies JA, Bard JB: The development of the kidney. Curr Top Dev Biol 1998, 39:245-301
25. - mutant mice result from defects in ureteric bud development. Development 1996, 122:1919-1929
26. Pichel JG, Shen L, Sheng HZ, Granholm A-C, Drago J, Grinberg A, Lee EJ, Huang SP, Saarma M, Hoffer BJ, Sariola H, Westphal H: Defects in enteric innervation and kidney development in mice lacking GDNF, Nature 1996, 382:73-76
27. Moore MW, Klein RD, Farinas I, Sauer H, Armanini M, Phillips H, Reichardl LF, Ryan AM, Carver-Moore K, Rosenthal A: Renal and neuronal abnormalities in mice lacking GDNF. Nature 1996, 382: 76-79
28. Sanchez MP, Silos-Santiago I, Frisen J, He B, Lira SA, Barbacid M: Renal agenesis and the absence of enteric neurons in mice lacking GDNF Nature 1996, 382:70-73
29. Bongarzone I, Vigano E, Alberti L, Borrello MG, Pasini B, Greco A, Mondellini P, Smith DP, Ponder BAJ, Romeo G, Pierotti MA: Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulation. Oncogene 1998, 16:2295-2301
30. Sweetser DA, Froelick GJ, Matsumoto AM, Kafer KE, Marck B, Palmiter RD, Kapur RP: Ganglioneuromas ana renal anomalies are induced by activated RetMEN2B in transgenic mice, Oncogene 1999, 18:877-886
31. Mercer EH, Hoyle GW, Kapur RP, Brinster RL, Palmiter RD: The dopamine β-hydroxylase gene promoter directs expression of E. coli lacZ to sympathetic and other neurons in adult transgenic mice. Neuron 1991, 7:703-716
32. Kapur RP, Hoyle GW, Mercer EH, Brinster RL, Palmiter RD: Some neuronal cell populations express human dopamine β-hydroxylase-lacZ transgenes transiently curing embryonic development Neuron 1991, 7:717-727
33. Southard-Smith EM, Kos L, Pavan WJ: Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model Nat Genet 1998, 18:60-64
34. Herbarth B, Pingault V, Bondurand N, Kuhlbrodt K, Hermans-Borgmeyer I, Puliti A, Lemort N, Goossens M, Wegner M: Mutation of the Sry-related Sox10 gene in Dominant megacolon, a mouse model for human Hirschsprung disease. Proc Natl Acad Sci USA 1998, 95: 5161-5165
35. Metallinos DL, Oppenheimer AJ, Rirchik EM, Russell LB, Dietrich W, Tilghman SM: Fine structure mapping and deletion analysis of the murine piebald locus. Genetics 1994, 136:217-223
36. Kapur RP, Livingston R, Doggett B, Sweetser DA, Siebert JR, Palmiter RD: Abnormal microenvironmental signals underlie intestinal aganglionosis in Dominant megacolon mutant mice Dev Biol 1996, 174:360-369
37. Sainio K, Suvanto P, Davies J, Wartiovaara J, Wartiovaara K, Saarma M, Arumae U, Meng X, Lindahl M, Pachnis V, Sariola H: Glial-cell-line-derived neurotrophic factor is required for bud initiation from ureteric epithelium. Development 1997, 124:4077-4087
38. Lane PW, Liu HM: Association of megacolon with a new dominant spotting gene (Dom) in the mouse. J Hered 1984, 75:435-439
39. Dom mouse embryos. Pediatr Dev Pathol 1999, 2:559-569
40. Sweetser DA, Kapur RP, Froelick GJ, Kafer KE, Palmiter RD Oncogenesis and altered differentiation induced by activated Ras in neuroblasts of transgenic mice. Oncogene 1997, 15:2783-2794
41. Hoyle GW, Mercer EH, Palmiter RD, Brinster RL: Expression of NGF in sympathetic neurons leads to excessive axon outgrowth from ganglia but decreased terminal innervation within tissues. Neuron 1993, 10: 1019-1034
42. Liu L, Barajas L: The rat renal nerves during development. Anat Embryol 1993, 188:345-361
43. Liu G-L, Liu L, Barajas L: Development of NOS-containing neuronal somata in the rat kidney. J Auton Nerv Sys 1996, 58:81-88
44. Liu L, Liu G-L, Barajas L: Distribution of nitric oxide synthase-containing neuronal somata and postganglionic fibers in the rat kidney. J Comp Neurol 1996, 369:16-30
45. Liu L, Liu GL, Barajas L Evidence for NOS-containmg renal neuronal somata transiently expressing a catecholaminergic phenotype during development in the rat. Neurosci Lett 1998, 251:161-164
46. Slotkin TA, Whitmore WL, Orband-Miller L, Queen KL, Haim K: Beta adrenergic control of macromolecule synthesis in neonatal rat heart, kidney, and lung: relationship to sympathetic neuronal development. J Pharmacol Exp Ther 1987, 243:101-109
47. Kaplan BS, Restaino I, Raval DS, Gottleib RP, Berstein J: Renal failure in the neonate with in utero exposure to non-steroidal anti-inflammatory agents. Pediatr Nephrol 1994, 8:700-704
48. Voyer LE, Drut R, Mendez JH: Fetal renal maldevelopment with oligohydramnios following maternal use of piroxicam. Pediatr Nephrol 1994, 8:592-594
49. Restaino I, Kaplan BS, Kaplan P, Rosenberg HK, Witzleben C. Roberts N: Renal dysgenesis in a monozygotic twin: association with in utero exposure to indomethacin. Am J Med Genet 1991, 39:252-257
50. Bernstein J, Werner AL, Verani R: Nonsteroidal anti-inflammatory drug fetal nephrotoxicity. Pediatr Dev Pathol 1998, 1:153-156
51. Gariepy CE, Williams SC, Richardson JA, Hammer RE, Yanagisawa M: Transgenic expression of the endothelin-B receptor prevents congenital intestinal aganglionosis in a rat model of Hirschsprung disease. J Clin Invest 1998, 102:1092-1101
52. - signaling on ureteric bud development. Development 1999, 126:1375-1386